Showing results (121-130 of 154) with videos related to

Sort By:
Pageof 16
Parkinsonism & Related Disorders|April 6, 2013
Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVERK Ray Chaudhuri, Pablo Martinez-Martin, Angelo Antonini, et al.
The Neurohospitalist|April 17, 2023
Inpatient Mortality in Parkinson's DiseaseOliver W Phillips, Zachary Kunicki, Richard Jones, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2006
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's diseaseJoseph H Friedman, Robert M Berman, Christopher G Goetz, et al.
The Journal of Clinical Psychiatry|June 9, 2025
Detecting Tardive Dyskinesia Using Video-Based Artificial IntelligenceAnthony A Sterns, Joel W Hughes, Bradley Grimm, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2006
Fatigue in Parkinson's disease: a reviewJoseph H Friedman, Richard G Brown, Cynthia Comella, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's diseaseJoseph H Friedman, Guido Alves, Peter Hagell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 5, 2008
Scales to assess psychosis in Parkinson's disease: Critique and recommendationsHubert H Fernandez, Dag Aarsland, Gilles Fénelon, et al.
The Journal of Clinical Psychiatry|January 25, 2024
The Clinician's Tardive Inventory (CTI): A New Clinical Tool for Documenting and Rating Tardive DyskinesiaRichard M Trosch, Cynthia L Comella, Stanley N Caroff, et al.
Parkinsonism & Related Disorders|April 5, 2025
A validation study of the Clinician's Tardive Inventory (CTI)Richard M Trosch, Alicia C Shillington, Cynthia L Comella, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 3, 2018
Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medicationsAlberto J Espay, Michael T Guskey, James C Norton, et al.
Pageof 16